10795--11/24/2010--BECTON_DICKINSON_&_CO

related topics
{product, liability, claim}
{regulation, government, change}
{customer, product, revenue}
{system, service, information}
{operation, international, foreign}
{acquisition, growth, future}
{financial, litigation, operation}
{product, market, service}
{cost, regulation, environmental}
Changes in reimbursement practices of third-party payers could affect the demand for our products and the prices at which they are sold. Price volatility could adversely affect costs associated with our operations. BD s future growth is dependent upon the development of new products, and there can be no assurance that such products will be developed. The medical technology industry is very competitive. A reduction or interruption in the supply of certain raw materials and components would adversely affect BD s manufacturing operations and related product sales. Interruption of our manufacturing operations could adversely affect BD s future revenues and operating income. BD is subject to a number of pending lawsuits. Consolidation in the healthcare industry could adversely affect BD s future revenues and operating income. Product defects could adversely affect the results of our operations. We may experience difficulties implementing our enterprise resource planning system. BD is subject to extensive regulation. We cannot guarantee that any of BD s strategic acquisitions, investments or alliances will be successful. The international operations of BD s business may subject BD to certain business risks.

Full 10-K form ▸
related documents
1000736--3/2/2006--CAREMARK_RX_INC
10795--11/25/2009--BECTON_DICKINSON_&_CO
313143--5/27/2008--HAEMONETICS_CORP
780127--1/12/2007--SYNOVIS_LIFE_TECHNOLOGIES__INC
780127--1/12/2006--SYNOVIS_LIFE_TECHNOLOGIES__INC
718924--12/27/2006--SPAN_AMERICA_MEDICAL_SYSTEMS_INC
1050007--11/30/2006--NUTRACEUTICAL_INTERNATIONAL_CORP
911649--4/2/2007--STRATEGIC_DIAGNOSTICS_INC/DE/
862668--9/29/2008--ESCALON_MEDICAL_CORP
7536--2/8/2008--ARROW_ELECTRONICS_INC
780127--1/5/2010--SYNOVIS_LIFE_TECHNOLOGIES__INC
874710--9/28/2006--ALLIED_HEALTHCARE_PRODUCTS_INC
10795--11/30/2006--BECTON_DICKINSON_&_CO
862668--10/12/2010--ESCALON_MEDICAL_CORP
10795--11/23/2007--BECTON_DICKINSON_&_CO
949874--3/14/2008--YOUNG_INNOVATIONS_INC
949874--3/15/2007--YOUNG_INNOVATIONS_INC
949874--3/14/2006--YOUNG_INNOVATIONS_INC
949874--3/12/2009--YOUNG_INNOVATIONS_INC
880432--9/28/2009--MISONIX_INC
810084--4/2/2007--BIOJECT_MEDICAL_TECHNOLOGIES_INC
768408--6/24/2010--CYANOTECH_CORP
40533--2/22/2008--GENERAL_DYNAMICS_CORP
811669--2/24/2006--UST_INC
1110783--10/26/2007--MONSANTO_CO_/NEW/
874710--9/26/2008--ALLIED_HEALTHCARE_PRODUCTS_INC
874710--9/28/2007--ALLIED_HEALTHCARE_PRODUCTS_INC
1006195--3/15/2007--MATRIXX_INITIATIVES_INC
31791--3/1/2010--PERKINELMER_INC
739944--3/10/2009--MEDTOX_SCIENTIFIC_INC